Cargando…
Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine
The global spread of multidrug-resistant strains of Neisseria gonorrhoeae constitutes a public health emergency. With limited antibiotic treatment options, there is an urgent need for development of a safe and effective vaccine against gonorrhea. Previously, we constructed a prototype vaccine candid...
Autores principales: | Gulati, Sunita, Pennington, Michael W., Czerwinski, Andrzej, Carter, Darrick, Zheng, Bo, Nowak, Nancy A., DeOliveira, Rosane B., Shaughnessy, Jutamas, Reed, George W., Ram, Sanjay, Rice, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831779/ https://www.ncbi.nlm.nih.gov/pubmed/31690678 http://dx.doi.org/10.1128/mBio.02552-19 |
Ejemplares similares
-
Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine
por: Gulati, Sunita, et al.
Publicado: (2019) -
Effect of gonococcal lipooligosaccharide variation on human monocytic cytokine profile
por: Patrone, Julia B, et al.
Publicado: (2007) -
Development of Complement Factor H–Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae
por: Shaughnessy, Jutamas, et al.
Publicado: (2020) -
Immunization against a Saccharide Epitope Accelerates Clearance of Experimental Gonococcal Infection
por: Gulati, Sunita, et al.
Publicado: (2013) -
An optimized Factor H-Fc fusion protein against multidrug-resistant Neisseria gonorrhoeae
por: Shaughnessy, Jutamas, et al.
Publicado: (2022)